Clinical Trials Browser

Phase 1/2 × Plasmacytoma × Immunotherapy, Adoptive × Clear all

NCT06429150 2024-06-10

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

Phase 1/2 Recruiting

Multiple Myeloma, Plasmacytoma